Profile data is unavailable for this security.
About the company
StemCell Institute Inc is mainly engaged in the cell bank business, which separates and stores cord blood. The Company operates cell bank business from umbilical cord blood and umbilical cord, development of new treatment methods and regenerative medicine products, regenerative medicine and fertility treatment, business development and investment in childbirth and childcare areas. The Company operates Cell Bank business segment. After signing the contract for the separation and storage of umbilical cord blood with customers (pregnant women), the umbilical cord blood collected at domestic umbilical cord blood collection cooperative hospitals (university hospitals, obstetric clinics and others) is collected, and carried into its cell processing center in Minato-ku, Tokyo and Midori-ku, Yokohama. It is stored at its cell storage center (Midori-ku, Yokohama, Kanagawa) for a long time at ultra-low temperature after stem cells contained in cord blood being separated, extracted and prepared.
- Revenue in JPY (TTM)2.40bn
- Net income in JPY280.72m
- Incorporated1999
- Employees92.00
- LocationStemCell Institute IncMatsuoka Tamuracho Bldg.5-22-10, ShimbashiMINATO-KU 105-0001JapanJPN
- Phone+81 368113230
- Fax+81 368113240
- Websitehttps://www.stemcell.co.jp/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aso International Inc | 3.31bn | 344.13m | 3.88bn | 267.00 | 11.36 | 1.56 | 10.19 | 1.17 | 70.22 | 70.22 | 674.77 | 511.54 | 1.23 | 12.41 | 9.01 | 12,400,770.00 | 12.74 | -- | 14.44 | -- | 44.76 | -- | 10.39 | -- | 6.68 | 245.05 | 0.00 | -- | 2.41 | -- | -3.89 | -- | -- | -- |
| Living Platform Ltd | 15.79bn | 132.75m | 4.66bn | 1.02k | 35.24 | 2.98 | 9.01 | 0.2953 | 29.45 | 29.45 | 3,517.39 | 348.49 | 1.40 | 413.23 | 8.51 | 15,435,750.00 | 1.18 | 1.99 | 1.68 | 2.84 | 8.50 | 11.29 | 0.8407 | 1.68 | 1.05 | -4.28 | 0.8114 | 0.00 | 17.80 | 19.25 | -77.52 | 3.74 | 17.23 | -- |
| Advantage Risk Management Co., Ltd. | 6.86bn | 476.33m | 6.77bn | 391.00 | 13.73 | 1.78 | 6.13 | 0.988 | 28.55 | 28.55 | 410.96 | 219.92 | 1.15 | -- | 7.92 | 17,535,230.00 | 7.96 | 8.52 | 12.54 | 13.68 | 69.99 | 75.92 | 6.95 | 8.38 | -- | -- | 0.0855 | 37.14 | 10.59 | 7.40 | 87.11 | -7.73 | 21.54 | 2.13 |
| As Partners Co Ltd | -100.00bn | -100.00bn | 6.93bn | 835.00 | -- | 2.95 | -- | -- | -- | -- | -- | 661.62 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.7527 | -- | 0.7404 | -- | 10.98 | -- | -52.63 | -- | -- | -- |
| Uchiyama Holdings Co Ltd | 28.40bn | 88.95m | 7.59bn | 2.33k | 76.69 | 0.5449 | 10.15 | 0.2671 | 4.58 | 4.58 | 1,468.15 | 644.21 | 0.9386 | 95.67 | 10.95 | 12,175,290.00 | 0.2939 | -1.45 | 0.4183 | -1.93 | 6.27 | 5.96 | 0.3132 | -1.63 | 1.62 | 11.22 | 0.5028 | -- | 7.83 | 0.3826 | 38.38 | -- | -0.1458 | -12.94 |
| Care Twentyone Corp | 42.07bn | -38.76m | 8.22bn | 5.91k | -- | 1.40 | 5.44 | 0.1955 | -2.87 | -2.87 | 3,121.08 | 395.28 | 1.17 | 749.33 | 7.53 | 7,123,649.00 | -0.1224 | 1.48 | -0.1735 | 1.96 | 21.66 | 22.97 | -0.1044 | 1.43 | 1.03 | -0.8588 | 0.7857 | 37.34 | 7.03 | 7.89 | -99.02 | -50.66 | 24.66 | 9.43 |
| Japan Hospice Holdings Inc | 9.87bn | 681.88m | 12.58bn | 963.00 | 18.13 | 4.57 | 11.50 | 1.27 | 84.26 | 84.26 | 1,219.93 | 334.02 | 0.7419 | -- | 6.65 | 10,251,160.00 | 5.12 | 4.43 | 5.93 | 5.29 | 19.48 | 19.68 | 6.91 | 5.49 | -- | 3.66 | 0.8018 | 0.00 | 25.05 | 26.77 | 49.95 | 35.47 | 87.38 | -- |
| StemCell Institute Inc | 2.40bn | 280.72m | 19.20bn | 92.00 | 68.40 | 7.42 | 48.46 | 8.01 | 27.40 | 27.40 | 233.93 | 252.66 | 0.4034 | 23.22 | 1.84 | 26,054,370.00 | 4.72 | 4.15 | 11.19 | 11.02 | 64.26 | 64.92 | 11.71 | 10.04 | 1.19 | -- | 0.00 | 0.00 | 17.36 | 19.41 | 48.09 | 23.28 | 29.64 | -- |
| I'rom Group Co Ltd | 17.32bn | 1.28bn | 22.62bn | 894.00 | 17.39 | 1.80 | 9.76 | 1.31 | 105.39 | 105.39 | 1,430.76 | 1,020.69 | 0.5038 | 5.40 | 5.88 | 19,376,960.00 | 3.71 | 8.08 | 5.54 | 11.17 | 44.59 | 42.65 | 7.36 | 11.77 | 1.04 | -- | 0.616 | 29.80 | 16.94 | 16.31 | 29.63 | 10.29 | 115.82 | 37.97 |
| Falco Holdings Co Ltd | 43.35bn | 2.00bn | 24.47bn | 1.16k | 12.08 | 0.9244 | 8.15 | 0.5644 | 182.71 | 182.71 | 3,935.60 | 2,388.67 | 1.15 | 15.11 | 6.72 | 37,402,070.00 | 5.31 | 5.39 | 7.14 | 7.55 | 30.10 | 31.06 | 4.60 | 4.19 | 2.08 | -- | 0.019 | 35.31 | -6.19 | 0.4104 | -36.00 | 5.91 | 8.77 | 8.79 |
| CellSource Co Ltd | 4.62bn | 851.00m | 29.49bn | 151.00 | 33.91 | 4.95 | 31.75 | 6.38 | 43.91 | 43.91 | 237.98 | 300.97 | 0.824 | 6.02 | 13.48 | 30,626,030.00 | 15.16 | 19.23 | 16.71 | 22.57 | 68.53 | 70.75 | 18.40 | 20.21 | 8.20 | -- | 0.00 | 12.89 | 5.54 | 30.04 | -9.30 | 36.70 | 70.54 | -- |
| Gakken Holdings Co Ltd | 168.66bn | 2.92bn | 41.38bn | 9.49k | 14.10 | 0.7771 | 6.21 | 0.2453 | 65.76 | 65.76 | 3,820.74 | 1,192.93 | 1.30 | 8.70 | 7.55 | 17,772,080.00 | 2.56 | 2.61 | 3.80 | 3.99 | 27.94 | 29.17 | 1.96 | 1.95 | 1.30 | 46.38 | 0.4466 | 33.86 | 5.18 | 8.93 | -7.15 | 0.8741 | -7.84 | 7.39 |
| CUC Inc | 33.02bn | 2.60bn | 46.85bn | 2.99k | 17.53 | 1.68 | 10.61 | 1.42 | 89.09 | 89.09 | 1,135.93 | 931.80 | 0.6438 | 294.86 | 3.89 | -- | 5.08 | -- | 7.24 | -- | 48.21 | -- | 7.90 | -- | 2.09 | -- | 0.4883 | -- | -6.21 | -- | 7.10 | -- | -- | -- |
Data as of May 10 2024. Currency figures normalised to StemCell Institute Inc's reporting currency: Japanese Yen JPY
3.31%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Meiji Yasuda Asset Management Co. Ltd.as of 12 Aug 2022 | 126.00k | 1.23% |
| Nikko Asset Management Co., Ltd.as of 19 Jul 2022 | 122.00k | 1.19% |
| Simplex Asset Management Co., Ltd.as of 04 Apr 2024 | 50.40k | 0.49% |
| Deutsche Asset Management (Japan) Ltd.as of 10 Mar 2022 | 25.40k | 0.25% |
| Dimensional Fund Advisors LPas of 31 Jan 2024 | 9.50k | 0.09% |
| SBI Okasan Asset Management Co. Ltd.as of 04 Sep 2023 | 4.40k | 0.04% |
| Amundi Japan Ltd.as of 12 Sep 2022 | 1.00k | 0.01% |
| SBI Asset Management Co., Ltd.as of 22 Jun 2023 | 0.00 | 0.00% |
| FIL Investments (Japan) Ltd.as of 15 Jul 2022 | 0.00 | 0.00% |
| Daiwa Asset Management Co. Ltd.as of 29 Aug 2022 | 0.00 | 0.00% |
More ▼
Data from 25 May 2023 - 19 Apr 2024Source: FactSet Research Systems Inc.
